selective serotonin reuptake inhibitor antidepressants
Showing 1 - 25 of >10,000
Risk Factors for AD-Associated Switch to Mania
Completed
- Bipolar Disorder
- Selective Serotonin Reuptake Inhibitors (SSRI), Serotonin-Norepinephrine Reuptake Inhibitor( SNRI), and Tricyclics.
-
Barcelona, Catalonia, SpainHospital Clinic Barcelona
Nov 17, 2021
Depressive Disorder, Major Trial in United States (JNJ-42847922, Placebo Matching to JNJ-42847922, Quetiapine XR)
Major Depressive Disorder With Anhedonia and Inadequate Response
Not yet recruiting
- Depressive Disorder, Major
- No Intervention
- (no location specified)
Apr 24, 2023
Major Depressive Disorder Who Have HadInadequate Response
Terminated
- Depressive Disorder, Major
- Standard of Care (SOC)
-
San Francisco, California
- +3 more
Dec 6, 2022
Depressive Disorder, Major Trial in Worldwide (Seltorexant, Placebo)
Recruiting
- Depressive Disorder, Major
- Seltorexant
- Placebo
-
San Diego, California
- +26 more
Aug 17, 2022
Haemorrhage Between Vortioxetine Tablet Treatment and Selective
Not yet recruiting
- Major Depressive Disorder
- Vortioxetine Tablet
- SSRI
- (no location specified)
Jun 28, 2023
Selective Serotonin Reuptake Inhibitor on Cognition, Sexual
Recruiting
- Menopause
- Hormone replacement therapy
- Selective serotonin reuptake inhibitors
-
São Bernardo do Campo, SP, BrazilCentro de Atenção Integral à Saúde da Mulher
Jan 20, 2022
Geriatric Depression, Cognitive Impairment Trial in Beijing (Selective Serotonin Reuptake Inhibitor(SSRIs,Fluoxetine,
Recruiting
- Geriatric Depression
- Cognitive Impairment
- Selective Serotonin Reuptake Inhibitor(SSRIs,Fluoxetine, paroxetine, fluvoxamine, sertraline, citalopram, escitalopram)
-
Beijing, ChinaBeijing Anding Hospital Affiliated to Capital Medical University
Oct 18, 2022
Hypercapnia, Ventilatory Depression Trial in West Bend (Placebo and Oxycodone, Paroxetine and Oxycodone, Escitalopram and
Not yet recruiting
- Hypercapnia
- Ventilatory Depression
- Placebo and Oxycodone
- +2 more
-
West Bend, WisconsinSpaulding Clinical Research
Jul 20, 2022
Percutaneous Tracheostomy in Clopidogrel and Selective Serotonin
Withdrawn
- Tracheostomy Complication
-
Columbus, Ohio
- +1 more
Nov 2, 2021
MDD Trial in Dhaka (Magnesium Glycinate tablet 200mg, Placebo tablet 200mg)
Completed
- MDD
- Magnesium Glycinate tablet 200mg
- Placebo tablet 200mg
-
Dhaka, BangladeshBasic Science and Paraclinical Science of BSMMU
Mar 6, 2022
Antidepressants in Advance of Investigational Trials
Recruiting
- Major Depressive Disorder
- FDA-approved selective-serotonin reuptake inhibitors (SSRIs) and selective-norepinephrine reuptake inhibitors (SNRIs)
-
Watertown, MassachusettsAdams Clinical
Mar 9, 2021
Depression in Old Age, Fragility Fracture Trial in Winston-Salem (Duloxetine 30 mg)
Not yet recruiting
- Depression in Old Age
- Fragility Fracture
- Duloxetine 30 mg
-
Winston-Salem, North CarolinaWake Forest University Health Sciences
May 9, 2023
Prospective Clinical Cohort Study of Depression
Not yet recruiting
- Major Depressive Disorder
- selective serotonin reuptake inhibitors
- TMS
- (no location specified)
Mar 7, 2023
PTSD Trial in United States (Selective serotonin reuptake inhibitor, Serotonin-norepinephrine reuptake inhibitor, Written
Recruiting
- PTSD
- Selective serotonin reuptake inhibitor
- +2 more
-
North Little Rock, Arkansas
- +15 more
Aug 2, 2022
Depression, Parkinson Disease Trial (Nortriptyline, Escitalopram, Placebo)
Recruiting
- Depression
- Parkinson Disease
- Nortriptyline
- +2 more
-
London, United KingdomRoyal Free London NHS Foundation Trust
Nov 2, 2022
Antidepressants in Advance of Investigational Trials, Relapse
Recruiting
- Major Depressive Disorder
- FDA-approved selective-serotonin reuptake inhibitors (SSRIs) and selective-norepinephrine reuptake inhibitors (SNRIs)
-
Watertown, MassachusettsAdams Clinical
Jun 14, 2021
Depressive Disorder, Major, Treatment Resistant Depression, Melancholia Trial in Ghent (device, behavioral, drug)
Recruiting
- Depressive Disorder, Major
- +2 more
- aiTBS
- +2 more
-
Ghent, East-Flanders, BelgiumUniversity Hospital Ghent
Dec 6, 2022
Depressive Disorder, Major Trial in Worldwide (Esketamine 28 mg, Esketamine 56 mg, Esketamine 84 mg)
Completed
- Depressive Disorder, Major
- Esketamine 28 mg
- +6 more
-
Ciudad Autonoma de Buenos Aires, Argentina
- +170 more
Sep 13, 2022
Fibromyalgia, Depression Trial in Dokki (Physiotherapy protocol, Selective serotonin reuptake inhibitors (SSRI))
Not yet recruiting
- Fibromyalgia
- Depression
- Physiotherapy protocol
- Selective serotonin reuptake inhibitors (SSRI)
-
Dokki, EgyptOutpatient clinic faculty of physica therapy cairo university
Mar 24, 2023
MDD Trial (Vortioxetine, Sertraline, citalopram)
Active, not recruiting
- Major Depressive Disorder
- Vortioxetine
- +6 more
-
Catanzaro, Italy
- +2 more
Oct 7, 2022
Depression, MDD, Dysthymic Disorder Trial in Indianapolis (behavioral, drug, other)
Completed
- Depression
- +7 more
- Beating the Blues (BtB)
- +3 more
-
Indianapolis, IndianaIUPUI Department of Psychology
Aug 30, 2021
DaTSCAN Brain Scintigraphy and Psychotropic Treatments:
Not yet recruiting
- Parkinson Disease
- scintigraphy DaTSCAN
-
Vandœuvre-lès-Nancy, FranceCHRU Nancy
Jan 5, 2023
Stroke, Ischemic Trial in White Plains (Administration of SSRI escitalopram, Paired Associative stimulation, Administration of
Withdrawn
- Stroke, Ischemic
- Administration of SSRI escitalopram
- +2 more
-
White Plains, New YorkBurke Neurological Institute
Jul 19, 2021
Meniere Disease Trial in Charleston (Venlafaxine, Placebo oral tablet)
Recruiting
- Meniere Disease
- Venlafaxine
- Placebo oral tablet
-
Charleston, South CarolinaMedical Univeristy of South Carolina
Dec 2, 2021